U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07716020) titled 'XPAD European Feasibility Study' on July 15.
Brief Summary: A prospective, single arm, non-randomized European feasibility study to evaluate the safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective lower-limb, above or below the knee, bypass surgery.
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Peripheral Arterial Disease
Intervention:
DEVICE: XPAD conduit
The XPAD bypass conduit is a sterile, restorative biodegradable polymer-based vascular conduit, consisting of a tubular structure with a 33cm length and 6mm inner diamet...